Log in to save to my catalogue

Reduction of lithium induced interstitial fibrosis on co-administration with amiloride

Reduction of lithium induced interstitial fibrosis on co-administration with amiloride

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01adcf60f5fe47748a8426486ca96408

Reduction of lithium induced interstitial fibrosis on co-administration with amiloride

About this item

Full title

Reduction of lithium induced interstitial fibrosis on co-administration with amiloride

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-08, Vol.12 (1), p.14598-14598, Article 14598

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Long-term administration of lithium is associated with chronic interstitial fibrosis that is partially reduced with exposure to amiloride. We examined potential pathways of how amiloride may reduce interstitial fibrosis. Amiloride was administered to a rat model of lithium induced interstitial fibrosis over a long term (6 months), as well as for sh...

Alternative Titles

Full title

Reduction of lithium induced interstitial fibrosis on co-administration with amiloride

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_01adcf60f5fe47748a8426486ca96408

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_01adcf60f5fe47748a8426486ca96408

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-18825-1

How to access this item